郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

肿瘤模型Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.

期刊：Bioconjugate chemistry发表年份：2012作者：Ryo Masuda; Shinya Oishi; Noriko Tanahara; Hiroaki Ohno; Akira Hirasawa; Gozoh Tsujimoto; Yoshiaki Yano; Katsumi Matsuzaki; Jean-Marc Navenot; Stephen C Peiper; Nobutaka Fujii
阅读更多 →

肿瘤模型Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1.

期刊：eLife发表年份：2012作者：Bray Denard; Ching Lee; Jin Ye
阅读更多 →

肿瘤模型A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation.

期刊：Growth factors (Chur, Switzerland)发表年份：2012作者：Eva J Koziolek; Jacqueline F Donoghue; John D Bentley; George Lovrecz; Olan Dolezal; Colin W Ward; Julie Rothacker; Edouard C Nice; Antony W Burgess; M Hafner; Terrance G Johns; Timothy E Adams
阅读更多 →

肿瘤模型Novel AKT1-GLI3-VMP1 pathway mediates KRAS oncogene-induced autophagy in cancer cells.

期刊：The Journal of biological chemistry发表年份：2012作者：Andrea E Lo Ré; Maite G Fernández-Barrena; Luciana L Almada; Lisa D Mills; Sherine F Elsawa; George Lund; Alejandro Ropolo; Maria I Molejon; Maria I Vaccaro; Martin E Fernandez-Zapico
阅读更多 →